Publications

Financing Biomedical Innovation

2022
Lo, Andrew W., and Richard T. Thakor (2022), Financing Biomedical Innovation, Annual Review of Financial Economics 14, 231–270.

Estimates of Probabilities of Successful Development of Pain Medications: An Analysis of Pharmaceutical Clinical Development Programs from 2000 to 2020

2022
Maher, Dermot P., Chi Heem Wong, Kien Wei Siah, and Andrew W. Lo (2022), Estimates of Probabilities of Successful Development of Pain Medications: An Analysis of Pharmaceutical Clinical Development Programs from 2000 to 2020, Anesthesiology 137, 243-251.

Should We Allocate More COVID-19 Vaccine Doses to Non-vaccinated Individuals?

2022
Ben Chaouch, Zied, Andrew W. Lo, and Chi Heem Wong (2022), Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?, PLOS Global Public Health 2 (7), e0000498.

Debiasing Probability of Success Estimates for Clinical Trials

2022
Chaudhuri, Shomesh, Joonhyuk Cho, Andrew W. Lo, Manish Singh, and Chi Heem Wong, Unpublished paper.

The reaction of sponsor stock prices to clinical trial outcomes: An event study analysis

2022
Singh, Manish, Roland Rocafort, Cathy Cai, Kien Wei Siah, Andrew W. Lo (2022), The reaction of sponsor stock prices to clinical trial outcomes: An event study analysis, PLoS ONE 17(9).

Measuring the Economic and Academic Impact of Philanthropic Funding: The Breast Cancer Research Foundation

2022
Vasileva, Detelina, Larry Norton, Marc Hurlbert, and Andrew W. Lo (2022), Measuring the Economic and Academic Impact of Philanthropic Funding: The Breast Cancer Research Foundation, Journal of Investment Management 20 (1), 5-24.

Multimorbidity and mortality: A data science perspective

2022
Siah, Kien Wei, Chi Heem Wong, Jerry Gupta, Andrew W. Lo (2022), Multimorbidity and mortality: A data science perspective, Journal of Multimorbidity and Comorbidity 12, https://doi.org/10.1177/26335565221105431.

Differentiated Dollars

2022
Alvarez, Daniel L., and Andrew W. Lo (2022), Differentiated Dollars, Nature Biotechnology 40, 458–462.

Financing Alzheimer’s Disease Drug Development

2022
Cummings, Jayna, Amanda Hu, Angela Su, and Andrew W. Lo (2022), Financing Alzheimer’s Disease Drug Development, In Alzheimer’s Disease Drug Development: Research and Development Ecosystem, edited by Jeffrey Cummings, Jefferson Kinney, and Howard Fillit, 465–479. Cambridge, UK: Cambridge University Press.

Sharing R&D Risk in Healthcare via FDA Hedges

2022
Jorring, Adam T., Andrew W. Lo, Tomas J. Philipson, Manita Singh, and Richard T. Thakor (2022), Sharing R&D Risk in Healthcare via FDA Hedges, Review of Corporate Finance Studies 11(4), 880–922.

Competition and R&D Financing: Evidence from the Biopharmaceutical Industry

2022
Thakor, Richard T., and Andrew W. Lo (2022), Competition and R&D Financing: Evidence from the Biopharmaceutical Industry, Journal of Financial and Quantitative Analysis 57 (5), 1885–1928.

Financing Vaccines for Global Health Security

2022
Vu, Jonathan T., Benjamin K. Kaplan, Shomesh E. Chaudhuri, Monique K. Mansoura, and Andrew W. Lo (2022), Financing Vaccines for Global Health Security, Journal Of Investment Management 20 (2), 51-67.

A Brainier Approach to ESG Investing

2021
Smith, Erin, Rashi Ojha, Andrew W. Lo, Jeffrey L. Cummings, William Hynes, and Harris Eyre (2021), Psychiatric Times, March 26.

Predicting drug approvals: The Novartis data science and artificial intelligence challenge

2021
Wei Siah, Kien, Nicholas W. Kelley, Steffen Ballerstedt, Bjorn Holzhauer, Tianmeng Lyu, David Mettler, Sophie Sun, Simon Wandel, Yang Zhong, Bin Zhou, Shifeng Pan, Yingyao Zhou, and Andrew W. Lo (2021), Predicting drug approvals: The Novartis data science and artificial intelligence challenge, Patterns 2 (8), 1-9.

Can Financial Economics Cure Cancer?

2021
Lo, Andrew W. (2021), Can Financial Economics Cure Cancer?, Atlantic Economic Journal 49, 3–21.